Investing in biotech outside of weight-loss drugs
GLP-1 weight-loss drugs have pushed the biotech sector to new heights as demand steadily increases. But despite the drugs' popularity, there are other investment opportunities within the biotech sector. Goldman Sachs lead analyst for the US …